Literature DB >> 28364823

Liver Retransplantation: How Much Is Too Much?

Jennifer Berumen1, Alan Hemming2.   

Abstract

Hepatic retransplantation has been surgically challenging since the beginning of liver transplant. Outcomes have improved over time, but patient survival with retransplant continues to be significantly worse than that of primary transplant. Many studies have focused on factors to predict outcomes. Models have been developed to help predict risk, but the decision for retransplant must be a multidisciplinary transplant team decision. The question of "when is too much?" can be guided by recipient and donor factors but is an ethical decision that must be made by the liver transplant team. Published by Elsevier Inc.

Entities:  

Keywords:  Hepatic retransplantation; Hepatitis C; Model for End-Stage Liver Disease; Primary transplant; Retransplant models

Mesh:

Year:  2017        PMID: 28364823     DOI: 10.1016/j.cld.2016.12.013

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  8 in total

1.  Association between common laboratory indices and IgAV recurrence in children.

Authors:  Juan Zhou; Li Li; Jing Luo; Yingtian Yang; Xing Shen
Journal:  BMC Pediatr       Date:  2022-10-19       Impact factor: 2.567

2.  Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort.

Authors:  Alyssa K Mezochow; Peter L Abt; Therese Bittermann
Journal:  Transplantation       Date:  2021-08-01       Impact factor: 5.385

Review 3.  Liver fibrosis: Pathophysiology and clinical implications.

Authors:  Jennifer Berumen; Jacopo Baglieri; Tatiana Kisseleva; Kristin Mekeel
Journal:  WIREs Mech Dis       Date:  2020-07-26

4.  Excellent Contemporary Graft Survival for Adult Liver Retransplantation: An Australian and New Zealand Registry Analysis From 1986 to 2017.

Authors:  Angus W Jeffrey; Luc Delriviere; Geoff McCaughan; Michael Crawford; Peter Angus; Robert Jones; Graeme A Macdonald; Jonathan Fawcett; Alan Wigg; John Chen; Ed Gane; Stephen Munn; Gary P Jeffrey
Journal:  Transplant Direct       Date:  2019-07-23

5.  Chronic rejection after liver transplantation: Opening the Pandora's box.

Authors:  Roberta Angelico; Bruno Sensi; Tommaso M Manzia; Giuseppe Tisone; Giuseppe Grassi; Alessandro Signorello; Martina Milana; Ilaria Lenci; Leonardo Baiocchi
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

6.  Intrahepatic De Novo Tumors in Liver Recipients are Highly Associated With Recurrent Viral Hepatitis.

Authors:  Michael J Pflüger; Max M Maurer; Karl H Hillebrandt; Andreas Andreou; Dominik Geisel; Moritz Schmelzle; Johann Pratschke; Dennis Eurich
Journal:  J Clin Exp Hepatol       Date:  2020-11-25

7.  Selected liver grafts from donation after circulatory death can be safely used for retransplantation - a multicenter retrospective study.

Authors:  Marjolein van Reeven; Otto B van Leeuwen; Danny van der Helm; Sarwa Darwish Murad; Aad P van den Berg; Bart van Hoek; Ian P J Alwayn; Wojciech G Polak; Robert J Porte
Journal:  Transpl Int       Date:  2020-03-09       Impact factor: 3.782

8.  Association between hospital liver transplantation volume and mortality after liver re-transplantation.

Authors:  Seung-Young Oh; Eun Jin Jang; Ga Hee Kim; Hannah Lee; Nam-Joon Yi; Seokha Yoo; Bo Rim Kim; Ho Geol Ryu
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.